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Washington University School of Medicine, St. Louis, Missouri, USA.
Phagocytosis is a key process in protection of the host against pathogens 
and in provision of antigens for the immune response. Synergism between 
C3b and IgG and their receptors in promoting adherence to and then inges-
tion of an antigen has been recognized for decades. Only more recently, 
however, has cross-talk between another complement activation fragment, 
the anaphylatoxin C5a, and Fcγ receptors (FcγRs) been defined. In this 
issue of the JCI, C5a is shown to signal, via its receptor, the upregulation of 
activating (proinflammatory-type) FcγRs (see the related article beginning 
on page 512). Moreover, engagement of FcγRs by the IgG-bearing immune 
complex instructs the cell to synthesize more C5, from which C5a is derived. 
Thus, this work establishes a feedback loop whereby FcγR expression and 
function are enhanced, a very desirable event in concert with an infection 
but potentially deleterious in autoimmunity.
Nonstandard abbreviations used: C, complement; 
C5aR, C5a anaphylatoxin receptor; FcγR, Fcγ receptor.
Conflict of interest: The author has declared that no 
conflict of interest exists.




Opsonins attach to invading microor-
ganisms and other antigens in order to 
enhance the uptake of foreign particles by 
phagocytes. The 2 most important opso-
nins in blood are Ig and complement (C). 
Specifically, IgG and C3b bind to a target 
where they serve as ligands for Fcγ and C 
receptors, respectively. This reaction can 
be conveniently split into 2 sequential 
steps; namely, immune adherence fol-
lowed by internalization. Early on, it was 
recognized that C3b and C receptors most 
effectively mediated the adherence step, 
while Fcγ receptors (FcγRs) most effective-
ly mediated the internalization step. This 
combination of “talents” ensures efficient 
phagocytosis of an infectious particle. As 
the humoral immune response rapidly 
matures, it deposits more and more IgG 
on particles, which subsequently elicits 
complement activation.
Many types of in vivo and in vitro experi-
ments have demonstrated how much more 
proficient C3b and IgG are as partners 
than either is alone in promoting phagocy-
tosis. C3b can mediate internalization but 
requires a relatively large ligand load and 
activated monocytes/macrophages. IgG 
can mediate adherence, but again, a heavy 
dose of ligand is necessary. However, a com-
bination of C3b and IgG is synergistic in 
mediating the phagocytic process. Thus, 
this cooperation between the receptors for 
these 2 ligands enhances this time-hon-
ored immune phenomenon that is critical 
to survival. In this issue of the JCI, Kumar, 
Gessner, and colleagues provide further 
evidence for another remarkable interac-
tion among complement-derived ligands, 
Igs, and their receptors (1).
$SPTTUBMLCFUXFFO$BBOE'Dγ3T
Kumar et al. (1) report a clear demonstra-
tion of cross-talk between the C and Ig 
receptors (Figure 1 and Table 1). In a mouse 
model of a so-called antibody-dependent, 
type II autoimmune reaction, the authors 
convincingly demonstrate the following 
interesting sequence of events: (a) upon 
injection of an autoantibody to mouse 
rbcs, immune complexes form that bind to 
FcγRs on liver macrophages (Kupffer cells); 
(b) these cells in turn secrete C5 and pos-
sibly a protease (yet to be clearly defined) 
that cleaves C5 into the anaphylatoxin 
C5a and the initiator of membrane attack 
complex, C5b; (c) C5a binds to its receptor 
(C5aR) on Kupffer cells, which upregulates 
FcγR mRNA expression; and then (d) the 
increased number of FcγRs on these mac-
rophages facilitates elimination of the 
antibody-coated rbcs, thereby leading to a 
more severe hemolytic anemia. While this 
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process is designed to “rev up” immune 
clearance in the setting of an infection by 
splenic and hepatic macrophages (once 
known as the reticuloendothelial system), 
it will of course also play out in immuno-
pathologic syndromes.
These data (1) are not the first to suggest 
this intriguing connection between C5a 
and FcγR. In 2 prior publications, includ-
ing one in the JCI, this same group estab-
lished that C5a initiates inflammation 
through its effects on FcγRs and through 
its more direct role as a cell activator and 
chemoattractant (2, 3). In the 2002 study, 
which used an acute immune complex 
pulmonary hypersensitivity model (2), 
C5aR engagement led to an increase in 
number and enhanced function of activat-
ing FcγRs (FcγRIII) versus the inhibitory 
FcγRs (FcγRII) on alveolar macrophages. 
If these changes did not occur, such as 
in C5aR-deficient animals, cytokine pro-
duction and neutrophil recruitment were 
impaired. In the more recent report (3), 
which used a similar model, but this time 
in the peritoneum of mice, C5aR activa-
tion was necessary to initiate neutrophil 
recruitment and to instruct a proinflam-
matory FcγR response.
While immune models can be set up to 
demonstrate that certain immunopatho-
logic conditions require only IgG and FcγR, 
or C and its receptors, most IgG-mediated 
events require FcγR engagement and com-
plement activation. Moreover, these events 
are commonly additive, if not synergistic, 
and, in many cases, interdependent. The 
animal species, site of inflammation, anti-
body types mediating the response, cellular 
location of receptors, and many other fac-
tors contribute to such immune responses. 
The issue is not necessarily one of “my sys-
tem is more important than yours,” but 
rather one of an improved definition of 
the timing, interactions, and synergies that 
mediate a given response. This understand-
ing has now been nicely demonstrated by 
Gessner and colleagues in the current 
study (1) and summarized by Gessner and 
Schmidt in a recent review (4).
An important point is that the use of C3-
deficient mice would not have been suffi-
cient to rule out a role for complement in the 
studies by Kumar et al. (1). The reason for 
this is straightforward but not appreciated 
or commented upon by most investigators. 
C5, like many complement components, 
may be synthesized locally by monocytes/
macrophages and other cell types, where it 
can be cleaved by proteases to produce C5a. 
This type of complement activation does not 
rely on any 1 of 3 pathways (classical, lectin, 
or alternative). A lack of appreciation for 
this possibility has led other investigators to 
mistakenly rule out an effect of the comple-
ment system, including those mediated by 
the upregulation of FcγRs following C5aR 
engagement (4, 5). C5 and C5aR knockout 
animals must be examined before a role for 
the complement system can be excluded.
'FFECBDLMPPQUPFOIBODF
'DγFYQSFTTJPO
Specifically, the 3 reports from the Gess-
ner group establish a feedback loop via 
cross-talk between 2 receptors (Figure 1). 
The early engagement of FcγR sends a sig-
nal to macrophages to provide a source of 
C5 from which C5a can be generated. C5a, 
through its receptor, in turn signals the cell 
to synthesize more FcγRs. The signal has 
specificity, as expression of the activating 
(proinflammatory) FcγRI and FcγRIII recep-
tors is upregulated, while expression of the 
inhibitory FcγRII receptor is either down-
modulated or unchanged. Many investiga-
tors have previously shown that “activated” 
macrophages, with their increased sup-
ply of FcγRs and other accoutrements, are 
more efficient at immune clearance and 
phagocytosis than resting cells (6). So, in 
many respects, these studies re-establish 
the importance of macrophage activation 
in the destruction of antibody- and C-tar-
geted antigens. While this feedback event 
was established in an animal model of pas-
sive transfer of an autoantibody, its physi-
ological role is to more efficiently eliminate 
bacteria and viruses from the bloodstream. 
There is much yet to be learned about the 
intracellular pathways in these signaling 
events and the control of this process.
A few caveats about the authors’ model 








Consequences of C5aR engagement for FcγRs 
1. ↑ in FcγRI expression 
Activating or proinflammatory receptors
2. ↑ in FcγRIII expression
3. No change or ↓ in FcγRII expression Inhibitory receptor
3FTVMUT"VHNFOUFE'Dγ3OVNCFSBOEGVODUJPOXIJDIJTEFTJSBCMFJOJOGFDUJPOTCVUVOEFTJSBCMFJO
IVNPSBMBVUPJNNVOJUZ
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tigators injected a single, large dose of an 
autoantibody that recognizes mouse rbcs to 
generate their cross-talk model system. The 
quantity of antibody used decreased the 
hematocrit from 50% to 25% in 4 days, even 
in FcγR–/– animals. Thus, C activation and 
rbc destruction took place via intravascular 
lysis and receptor-mediated extravascular 
sequestration (7). Complement activation 
occurs rapidly (within seconds) in this model 
and would provide another source of C5a to 
enhance FcγR mRNA expression; this may be 
the most likely C5a source in vivo. Second, 
the authors do not establish the mechanism 
for generating C5a. They hypothesize that a 
protease cleaves C5. Third, while they dem-
onstrate upregulation of FcγRI and FcγRIII 
mRNA expression, they do not document an 
increased number of FcγRs on Kupffer cells 
in vitro or in vivo. Fourth, the authors nicely 
establish that FcγRII (the FcγR that sends a 
negative or antiinflammatory signal) plays 
no role in their observations. The reason 
here is simple: Kupffer cells do not express 
this receptor, although FcγRII was expressed 
on sinusoidal cells.
*NNVOPQBUIPMPHJDSFBDUJPOT
As a final comment, in their study, Kumar 
et al. (1) refer to their model as an anti-
body-dependent type II autoimmune reac-
tion. Antibodies of this type are directed 
at cell-bound targets (in the case of auto-
immune hemolytic anemia) or matrix 
proteins (in the case of Goodpasture syn-
drome). The most up-to-date immunol-
ogy textbooks still all have tables show-
ing the Gell and Coombs classification 
system of immunopathologic reactions 
(8). I first learned about this system, as 
did many aspiring immunologists of my 
generation, at the NIH, where we were so 
fortunate to have Bill Paul as our teacher 
in the immunology course. I have now 
been teaching this same classification sys-
tem for 30-plus years to students at Wash-
ington University School of Medicine. 
Students and senior immunologists still 
find it a useful scheme to classify immune 
reactions that we would like to be able to 
better control. Hopefully, insights pro-
vided by studies like those of Gessner’s 
group will eventually provide us with the 
tools to accomplish this goal.
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Mucous hypersecretion is a major cause of airway obstruction in asthma, 
chronic obstructive pulmonary disease, and cystic fibrosis. EGFR ligands 
and IL-13 are known to stimulate mucous induction, but the detailed mecha-
nisms of epithelial mucous regulation have not been well defined. In this 
issue of the JCI, Tyner et al. show, in a mouse model of chronic mucous 
hypersecretion, that ciliated epithelial cell apoptosis is inhibited by EGFR 
activation, allowing IL-13 to stimulate the differentiation of these cells into 
goblet cells, which secrete mucus (see the related article beginning on page 
309). In defining this coordinated, 2-step process, we can consider the thera-
peutic effects of blocking mucous production. This begs the question, Is it 
possible to reduce airway obstruction in chronic lung disease by inhibiting 
EGFR activation and/or by inhibiting IL-13?
Nonstandard abbreviations used: COPD, chronic 
obstructive pulmonary disease.
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In the respiratory tract, mucus is a critical 
component of the innate host defense sys-
tem. On the airway epithelial cell surface, 
the sticky gel layer traps particles and the 
sol layer, which is predominantly water, con-
tacts the surface of ciliated cells and permits 
moving of the gel out of the lower airways 
like an escalator so that it can ultimately be 
cleared by coughing or swallowing. Mucus 
also contains antibacterial agents to aid in 
its defense function. Pathogens and harm-
less proteins we inhale are thus removed 
from the respiratory tract and have a limited 
encounter with other immune components. 
In the bronchial airways, mucus is produced 
by surface epithelial cells with secretory fea-
tures and a classical goblet shape, called 
goblet cells. Goblet cells produce mucins 
that are complexed with water in secretory 
granules and are released into the airway 
lumen. In the large airways, mucus is also 
produced by mucous glands. Under basal 
conditions, the columnar epithelial surface 
comprises a small percentage of goblet cells 
and a majority of ciliated cells. This struc-
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